Shenyang Xingqi Eye Drops

Shenyang Xingqi Pharmaceutical is a leading Chinese high-tech enterprise specializing in the research, development, production, and sale of ophthalmic medications. Founded in 1977 and headquartered in Shenyang, the company offers a comprehensive portfolio of eye care solutions, including treatments for myopia progression in children, dry eye syndrome, and various ocular infections and inflammations. Its flagship products include low-concentration atropine sulfate eye drops and cyclosporine eye drops. The company is publicly traded on the Shenzhen Stock Exchange (300573.SZ) and operates its own eye hospital and advanced manufacturing facilities.